Symptom or adverse drug reaction? An investigation into how symptoms are recognised as side effects of medication

Pharmaceutical Journal

Volumn 269, Issue 7224, 2002, Pages 719-722

  Hughes, M Louise ^a   Whittlesea, Cate M C ^a   Luscombe, David K ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; DETERGENT; FERROUS SULFATE; IBUPROFEN; NON PRESCRIPTION DRUG;

ADOLESCENT; ADVERSE DRUG REACTION; ARTICLE; AWARENESS; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; CONSULTATION; CONTROLLED STUDY; DISEASE SEVERITY; DOCTOR PATIENT RELATION; DRUG SURVEILLANCE PROGRAM; FEMALE; GASTROINTESTINAL SYMPTOM; GENERAL PRACTITIONER; HEADACHE; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEALTH PRACTITIONER; HUMAN; MALE; MEDICAL DECISION MAKING; MEDICAL SOCIETY; OCCUPATION; PATIENT COUNSELING; PATIENT EDUCATION; PHARMACIST; PHARMACY; RASH; RELIABILITY; RISK BENEFIT ANALYSIS; SCHOOL CHILD; SOCIOECONOMICS; VERTIGO;

EID: 0037121323     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Bem JL, Wood SM, West L, Rawlins MD, Breckenridge AM. 25 years of the Committee on Safety of Medicines. An international perspective of the benefits. Drug Safety 1990;5:161-7.
2. Committe on Safety of Medicines/Medicines Control Agency. Advice about adverse drug reaction reporting. Curr Prob Pharmacovigilance 1999;25:4.
3. "Yellow card" reporting now allowed for all community pharmacists. Pharm J 1999;263:776.
4. Fisher S, Bryant SG, Kent TA, Davis JE, Patient drug attributions and postmarketing surveillance. Pharmacotherapy 1994;14:202-9.
5. Houghton J, Woods F, Davis S, Coulson R, Routledge PA. Community pharmacist reporting of suspected ADRs: (2) Attitudes of community pharmacists and general practitioners in Wales. Pharm J 1999;253:788-91.
6. Kreuger RA. Focus groups (2nd ed). London: Sage Publications; 1994.
7. Koch-Weser J, Sellers EM, Zacest R. The ambiguity of adverse drug reactions. Eur J Clin Pharmacol 1977;11:75-8.
8. Barnes J, Mills SY, Abbot NC, Willoughby M, Ernst E. Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal remedies. Br J Clin Pharmacol 1998;45:496-500.
9. Martin RM, Kapoor KV, Wilton LV, Mann RD. Under-reporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational study. BMJ 1998;317:119-20.
10. Krska J, Kennedy E. Expectations and experiences of customers purchasing over-the-counter medicines in pharmacies in the North of Scotland. Pharm J 1996;256:354-6.
11. Pharmacists' adverse drug reaction reporting to start on April 1. Pharm J 1997;258:330-1.